Krka released the 2022 unaudited financial statements of the Krka Group and the controlling company Krka, d. d., Novo mesto today. The report was published on the Ljubljana Stock Exchange website after being discussed by the company's Supervisory Board at their meeting yesterday. The Krka Group revenue in 2022 totalled €1,717.5 million, up 10% on 2021, the highest since incorporation. The Krka Group's unaudited net profit was €363.7 million, an increase by €55.5 million year-over-year, or 18%, i.e. also the highest so far. The 2022 Annual Report is being released on Thursday, 13 April 2023.
The President of the Management Board and Chief Executive Jože Colarič explained: "As reported in January, Krka Group operations in 2022 were successful and in line with expectations. The actual full-year sales value remains as reported in the 2022 unaudited performance estimate, while operating profit and net profit have exceeded our estimates by €0.9 million and by €2.5 million, respectively. Last year's performance testifies to the fact that we are responsive and well-prepared to adapt instantly to new opportunities and challenges arising from changed circumstances, and this is owing to our resilient vertically integrated business model. We will continue to pursue this model also in the future."
Financial highlights
€ thousand
Krka Group
Company
2022*
2021
Index
2022*
2021
Index
Revenue
1,717,453
1,565,802
110
1,553,514
1,381,367
112
- Of that revenue from contracts with customers (products and services)
1,708,542
1,560,288
110
1,356,075
1,211,494
112
Gross profit
974,393
891,208
109
890,182
766,535
116
Earnings before interest, tax, depreciation and amortisation (EBITDA)
488,895
463,625
105
440,086
358,188
123
Operating profit (EBIT)
381,211
354,788
107
357,870
273,325
131
Profit before tax (EBT)
433,073
362,417
119
412,258
285,956
144
Net profit
363,662
308,150
118
348,215
245,216
142
R&D expenses
162,580
154,559
105
158,292
150,232
105
Investments
105,974
66,386
160
79,540
49,493
161
Performance Ratios
Krka Group
Company
2022*
2021
2022*
2021
Gross profit margin
56.7%
56.9%
57.3%
55.5%
EBITDA margin
28.5%
29.6%
28.3%
25.9%
EBIT margin
22.2%
22.7%
23.0%
19.8%
EBT margin
25.2%
23.1%
26.5%
20.7%
Net profit margin (ROS)
21.2%
19.7%
22.4%
17.8%
Return on equity (ROE)
17.9%
16.8%
17.7%
13.4%
Return on assets (ROA)
13.9%
12.9%
14.1%
10.6%
Liabilities/Equity
0.257
0.322
0.221
0.294
R&D expenses/Revenue
9.5%
9.9%
10.2%
10.9%
* The 2022 data are unaudited.
Krka Group Sales
Sales growth was recorded in all sales regions and most sales markets, for all product groups and services.
Product and Service Sales by Region
In 2022, the Krka Group generated €1,708.5 million of revenue from contracts with customers on the sales of products and services, an increase by €148.3 million or 10% compared to the 2021 results.
KRKA dd published this content on 16 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2023 07:52:08 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
